233 related articles for article (PubMed ID: 21398193)
1. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
Roth C; Pantel K; Müller V; Rack B; Kasimir-Bauer S; Janni W; Schwarzenbach H
BMC Cancer; 2011 Jan; 11():4. PubMed ID: 21211028
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.
Roth C; Rack B; Müller V; Janni W; Pantel K; Schwarzenbach H
Breast Cancer Res; 2010; 12(6):R90. PubMed ID: 21047409
[TBL] [Abstract][Full Text] [Related]
4. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
Fleischhacker M; Schmidt B
Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
[TBL] [Abstract][Full Text] [Related]
5. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients.
Wimberger P; Roth C; Pantel K; Kasimir-Bauer S; Kimmig R; Schwarzenbach H
Int J Cancer; 2011 Jun; 128(11):2572-80. PubMed ID: 20715113
[TBL] [Abstract][Full Text] [Related]
6. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma.
Deligezer U; Erten N; Akisik EE; Dalay N
Exp Mol Pathol; 2006 Feb; 80(1):72-6. PubMed ID: 15961076
[TBL] [Abstract][Full Text] [Related]
7. Circulating nucleic acids as biomarkers in breast cancer.
Schwarzenbach H
Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
[TBL] [Abstract][Full Text] [Related]
8. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients.
Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY
EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiles of whole blood in lung adenocarcinoma.
Patnaik SK; Yendamuri S; Kannisto E; Kucharczuk JC; Singhal S; Vachani A
PLoS One; 2012; 7(9):e46045. PubMed ID: 23029380
[TBL] [Abstract][Full Text] [Related]
10. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer.
Soliman SE; Abdelaleem AH; Alhanafy AM; Ibrahem RAL; Elhaded ASA; Assar MFA
Mol Biol Rep; 2021 Mar; 48(3):2543-2552. PubMed ID: 33837901
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
13. Genomic tests: unreliable for cancer? A focus on circulating DNA and lung cancer.
Teare MD; Woll PJ
Expert Rev Mol Diagn; 2007 Nov; 7(6):699-702. PubMed ID: 18020899
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
15. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
16. Correlation analysis between liver metastasis and serum levels of miR‑200 and miR‑141 in patients with colorectal cancer.
Ding M; Zhang T; Li S; Zhang Y; Qiu Y; Zhang B
Mol Med Rep; 2017 Nov; 16(5):7791-7795. PubMed ID: 28944840
[TBL] [Abstract][Full Text] [Related]
17. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs - a new horizon in molecular diagnosis of breast cancer.
Hagrass HA; Sharaf S; Pasha HF; Tantawy EA; Mohamed RH; Kassem R
Genes Cancer; 2015 May; 6(5-6):281-7. PubMed ID: 26124926
[TBL] [Abstract][Full Text] [Related]
19. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
20. PCR-free, microfluidic single molecule analysis of circulating nucleic acids in lung cancer patient serum.
Liu KJ; Wang TH
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():8392-5. PubMed ID: 22256294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
